Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-LACTULOSE | 667MG | SOLUTION | Resolved | 2023-02-02 | 2023-04-28 | 183401 |
LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Resolved | 2023-02-10 | 2023-03-23 | 184317 |
EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2023-02-17 | 2023-04-28 | 185077 |
CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2023-04-27 | 2023-06-09 | 190671 |
TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2023-04-27 | 2023-06-27 | 190674 |
EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2023-06-08 | 2023-10-03 | 194144 |
TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2023-06-08 | 2023-06-21 | 194160 |
PEDIATRIX | 160MG | SOLUTION | Resolved | 2023-06-16 | 2023-06-27 | 195106 |
CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2023-06-16 | 2023-08-18 | 195121 |
DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2023-06-16 | 2023-07-05 | 195219 |
TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2023-06-19 | 2023-06-27 | 195618 |
PEDIATRIX | 160MG | SOLUTION | Resolved | 2023-06-19 | 2023-06-27 | 195643 |
TEVA-LACTULOSE | 667MG | SOLUTION | Resolved | 2023-06-20 | 2023-10-03 | 195766 |
EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2023-06-20 | 2023-07-05 | 195784 |
DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2023-06-20 | 2023-10-19 | 195806 |
TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Actual shortage | 2023-07-11 | 2024-06-13 | 198292 |
TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2023-10-19 | 2024-06-13 | 207512 |
EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2023-10-19 | 2023-11-30 | 207533 |
TEVA-SALBUTAMOL STERINEBS P.F. | 1MG | SOLUTION | Actual shortage | 2024-01-11 | 2024-05-03 | 215707 |
TEVA-LATANOPROST | 50MCG | SOLUTION | Actual shortage | 2024-02-08 | 2024-03-21 | 218963 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
TEVA-TECNAL C 1/4 | 330MG 50MG 15MG 40MG | CAPSULE | Discontinued | 2019-04-11 | 2019-04-11 | 81353 |